/term/roe-adj/XKRX:122310 Genoray Co (XKRX:122310) ROE % Adjusted to Book Value
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genoray Co Ltd (XKRX:122310) » Definitions » ROE % Adjusted to Book Value

Genoray Co (XKRX:122310) ROE % Adjusted to Book Value : 9.38% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genoray Co ROE % Adjusted to Book Value?

Genoray Co's ROE % for the quarter that ended in Mar. 2024 was 9.10%. Genoray Co's PB Ratio for the quarter that ended in Mar. 2024 was 0.97. Genoray Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 9.38%.


Genoray Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Genoray Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genoray Co ROE % Adjusted to Book Value Chart

Genoray Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.15 7.72 11.01 13.55 13.62

Genoray Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.67 14.39 12.17 16.63 9.38

Competitive Comparison of Genoray Co's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Genoray Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genoray Co's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genoray Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genoray Co's ROE % Adjusted to Book Value falls into.



Genoray Co ROE % Adjusted to Book Value Calculation

Genoray Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=13.62% / 1.00
=13.62%

Genoray Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.10% / 0.97
=9.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genoray Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genoray Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Genoray Co (XKRX:122310) Business Description

Traded in Other Exchanges
N/A
Address
No. 512, 560, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 462-716
Genoray Co Ltd manufactures and sells medical and dental systems in South Korea. The company has developed the 3DCT software for medical and dental applications and developed innovative 3D software for dentistry. The product portfolio includes OSCAR prime, ZEN-7000, MX-600, PORT-X II, PORT-X IV, and PAPAYA.

Genoray Co (XKRX:122310) Headlines

No Headlines